SELECT ?property ?value WHERE { BIND (?? AS ?s) ?s ?property ?value . FILTER (isLiteral(?value)) } LIMIT 1000

Attributes

Pharmakopöe
pharmacopoeia
pharmacopée
farmacopea
Sammlung von Vorschriften über die Qualität von Arzneimitteln, pharmazeutischen Hilfsstoffen und einzelnen Medizinprodukten.
Collection of regulations on the quality of medicinal products, excipients and certain medical devices.
Recueil de prescriptions relatives à la qualité des médicaments, des excipients et de certains dispositifs médicaux.
Raccolta di prescrizioni sulla qualità dei medicamenti, delle sostanze ausiliarie farmaceutiche e di singoli dispositivi medici.
2024-04-30T08:12:25.9176960Z
492991
https://www.termdat.bk.admin.ch/entry/492991
Heilmittelgesetz, Art. 4 Abs. 1 Bst. g (SR 812.21, Stand 2024-01)
Therapeutic Products Act, art. 8 (SR 812.21, transl., status 2024-01)
LF Produits thérapeutiques, art. 8 (RS 812.21, état 2024-01)
LF Agenti terapeutici, art. 8 (RS 812.21, stato 2024-01)
EXP: z. B.. Pharmacopoea Europaea oder Pharmacopoea Helvetica
USG: upper case when referring to a specific pharmacopoeia; EXP: e.g. Pharmacopoea Europaea or Pharmacopoea Helvetica
USG: en majuscule lorsqu'il s'agit d'une pharmacopée spécifique; EXP: p. ex. Pharmacopoea Europaea ou Pharmacopoea Helvetica
USG: con la maiuscola quando si fa riferimento a una farmacopea specifica; EXP: p. es. Pharmacopoea Europaea o Pharmacopoea Helvetica
nach Heilmittelgesetz, Art. 4 Abs. 1 Bst. g (SR 812.21, Stand 2024-01
(USG) after Therapeutic Products Act, art. 8 (SR 812.21, transl., status 2024-01); (EXP) after Therapeutic Products Act, art. 4 para. 1 let. g (SR 812.21, transl., status 2024-01)
(USG) d'après LF Produits thérapeutiques, art. 8 (RS 812.21, état 2024-01); (EXP) d'après LF Produits thérapeutiques, art. 4 al. 1 let. g (RS 812.21, état 2024-01)
(USG) secondo LF Agenti terapeutici, art. 8 (RS 812.21, stato 2024-01); (EXP) secondo LF Agenti terapeutici, art. 4 cpv. 1 lett. g (RS 812.21, stato 2024-01)
Heilmittelgesetz, Art. 4 Abs. 1 Bst. g (SR 812.21, Stand 2024-01
Therapeutic Products Act, art. 4 para. 1 let. g (SR 812.21, transl., status 2024-01)
LF Produits thérapeutiques, art. 4 al. 1 let. g (RS 812.21, état 2024-01)
LF Agenti terapeutici, art. 4 cpv. 1 lett. g (RS 812.21, stato 2024-01)
SELECT ?property ?object WHERE { BIND (?? AS ?s) ?s ?property ?object . FILTER (isIRI(?object)) FILTER (?property != rdf:type) FILTER (?property != rdfs:subClassOf) } LIMIT 1000
SELECT ?property ?subject WHERE { BIND (?? AS ?o) ?subject ?property ?o . FILTER (?property != rdf:type) FILTER (?property != rdfs:subClassOf) } LIMIT 1000

Incoming Relationships

property subject
seeAlso Swiss Pharmacopoeia Commission
SELECT ?instance ?description WHERE { BIND (?? AS ?class) ?instance (rdf:type|owl:type) ?class . OPTIONAL { ?instance schema:description ?description . } } LIMIT 5000
Instances of this Class: No results found.
SELECT ?superclass ?description WHERE { ?? rdfs:subClassOf ?superclass . OPTIONAL { ?superclass (rdfs:comment|schema:description) ?description . } } LIMIT 5000
Superclasses of this Class: No results found.
SELECT ?subclass ?description WHERE { ?subclass rdfs:subClassOf ?? . OPTIONAL { ?subclass (rdfs:comment|schema:description) ?description . } } LIMIT 5000
Subclasses of this Class: No results found.